Yoshiaki Kobayashi1, Daiki Fukuhara2, Dai Akase2, Misako Aida2, Kumiko Ui-Tei1,3. 1. Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan. 2. Center for Quantum Life Sciences and Department of Chemistry, Graduate School of Science, Hiroshima University, Higashi-Hiroshima 739-8526, Japan. 3. Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8561, Japan.
Abstract
In RNA interference (RNAi), small interfering RNA (siRNA) functions to suppress the expression of its target mRNA with perfect sequence complementarity. In a mechanism different from above, siRNA also suppresses unintended mRNAs with partial sequence complementarities, mainly to the siRNA seed region (nucleotides 2-8). This mechanism is largely utilized by microRNAs (miRNAs) and results in siRNA-mediated off-target effects. Thus, the siRNA seed region is considered to be involved in both RNAi and off-target effects. In this study, we revealed that the impact of 2'-O-methyl (2'-OMe) modification is different according to the nucleotide positions. The 2'-OMe modifications of nucleotides 2-5 inhibited off-target effects without affecting on-target RNAi activities. In contrast, 2'-OMe modifications of nucleotides 6-8 increased both RNAi and off-target activities. The computational simulation revealed that the structural change induced by 2'-OMe modifications interrupts base pairing between siRNA and target/off-target mRNAs at nucleotides 2-5 but enhances at nucleotides 6-8. Thus, our results suggest that siRNA seed region consists of two functionally different domains in response to 2'-OMe modifications: nucleotides 2-5 are essential for avoiding off-target effects, and nucleotides 6-8 are involved in the enhancement of both RNAi and off-target activities.
In RNA interference (RNAi), small interfering RNA (siRNA) functions to suppress the expression of its target mRNA with perfect sequence complementarity. In a mechanism different from above, siRNA also suppresses unintended mRNAs with partial sequence complementarities, mainly to the siRNA seed region (nucleotides 2-8). This mechanism is largely utilized by microRNAs (miRNAs) and results in siRNA-mediated off-target effects. Thus, the siRNA seed region is considered to be involved in both RNAi and off-target effects. In this study, we revealed that the impact of 2'-O-methyl (2'-OMe) modification is different according to the nucleotide positions. The 2'-OMe modifications of nucleotides 2-5 inhibited off-target effects without affecting on-target RNAi activities. In contrast, 2'-OMe modifications of nucleotides 6-8 increased both RNAi and off-target activities. The computational simulation revealed that the structural change induced by 2'-OMe modifications interrupts base pairing between siRNA and target/off-target mRNAs at nucleotides 2-5 but enhances at nucleotides 6-8. Thus, our results suggest that siRNA seed region consists of two functionally different domains in response to 2'-OMe modifications: nucleotides 2-5 are essential for avoiding off-target effects, and nucleotides 6-8 are involved in the enhancement of both RNAi and off-target activities.
RNA
interference (RNAi) is a post-transcriptional gene-silencing
mechanism triggered by small interfering RNA (siRNA), which is a 21-nucleotide-long
double-stranded RNA with two-nucleotide 3′ overhangs.[1−5] When the siRNA duplex is introduced into cells, it is loaded onto
the Argonaute (AGO) protein, a core protein of the RNA-induced silencing
complex (RISC) (Figure A).[6−10] On the AGO protein, the duplex is unwound into two RNA strands,
one of which (the guide strand) remains on the AGO protein, whereas
the other (the passenger strand) is degraded.[11−14] The guide strand recognizes the
target mRNA with perfect sequence complementarity, and the target
mRNA is cleaved by AGO2, resulting in the suppression of the target
gene.[8−10] Thus, RNAi is widely recognized as a powerful tool
for functional genomics and a promising candidate for therapeutic
applications. RNAi and the related RNA silencing mechanisms are observed
in a variety of evolutionarily diverse organisms.[15] However, effective siRNAs are limited in mammalian cells;
the identification of functional siRNA sequence rules is essential
for developing effective mammalian RNAi. We previously found that
siRNAs that simultaneously satisfy the following four sequence conditions
are functional: (i) A/U at the 5′ end of the siRNA guide strand,
(ii) G/C at the 5′ end of the passenger strand, (iii) four
or more A/U residues in the seven-nucleotide 5′ terminus of
the guide strand, and (iv) no G/C stretch ≥9 nucleotides long
(Figure B).[16] The siRNAs that satisfy all of these four rules
simultaneously are classified as class I siRNAs. By contrast, siRNAs
that satisfy none of these conditions are classified into class III,
and those classified into neither class I nor III are named as class
II. The importance of these conditions has been verified in a number
of studies, and the asymmetry in the stabilities of both siRNA termini
is essential for determining the unwinding direction of the siRNA
duplex into single-stranded RNAs.[17−19] The 5′-terminus
unwound from unstable termini is anchored in a binding pocket in the
MID-domain of the AGO protein. The binding affinity of A or U at the
5′ terminus in the pocket is 30-fold higher than that of either
G or C.[20] Thus, an RNA strand with an unstable
5′ terminus acts as a functional guide RNA.
Figure 1
Schematic representation
of siRNA-mediated RNAi and off-target
effects. (A) The siRNA is a double-stranded RNA composed of 21-nucleotide-long
guide and passenger strands. siRNA transfected into cells is loaded
onto the AGO2 protein, and the passenger strand is removed. The guide
strand base-pairs with target and off-target mRNAs through sequence
complementarity with the seed region. The guide RNA then base-pairs
with target mRNA with a perfect complementary sequence and cleaves
it with AGO2 to repress its expression. On the other hand, the expression
of off-target mRNAs with sequences complementary to the siRNA seed
region is reduced by off-target effects, which is a mechanism like
miRNA-mediated translational repression. (B) In mammalian cells, a
limited fraction of siRNAs is known to be functional. According to
the levels of predicted silencing activities, siRNAs are classified
into classes I, II, and III. Class I siRNA is a functional siRNA in
mammalian cells. Class I siRNA has A/U at the 5′ end of the
guide strand, G/C at the 5′ end of the passenger strand, more
than 4 A/Us in the seven-nucleotide 5′ terminus of the guide
strand, and no GC stretch longer than eight nucleotides. Class III
siRNA is a nonfunctional siRNA and has G/C at the 5′ end of
the guide strand, A/U at the 5′ end of the passenger strand,
and more than 4 G/Cs within the seven-nucleotide region at the 5′
end of the guide strand. Class II siRNAs are those classified into
neither class I nor class III.
Schematic representation
of siRNA-mediated RNAi and off-target
effects. (A) The siRNA is a double-stranded RNA composed of 21-nucleotide-long
guide and passenger strands. siRNA transfected into cells is loaded
onto the AGO2 protein, and the passenger strand is removed. The guide
strand base-pairs with target and off-target mRNAs through sequence
complementarity with the seed region. The guide RNA then base-pairs
with target mRNA with a perfect complementary sequence and cleaves
it with AGO2 to repress its expression. On the other hand, the expression
of off-target mRNAs with sequences complementary to the siRNA seed
region is reduced by off-target effects, which is a mechanism like
miRNA-mediated translational repression. (B) In mammalian cells, a
limited fraction of siRNAs is known to be functional. According to
the levels of predicted silencing activities, siRNAs are classified
into classes I, II, and III. Class I siRNA is a functional siRNA in
mammalian cells. Class I siRNA has A/U at the 5′ end of the
guide strand, G/C at the 5′ end of the passenger strand, more
than 4 A/Us in the seven-nucleotide 5′ terminus of the guide
strand, and no GC stretch longer than eight nucleotides. Class III
siRNA is a nonfunctional siRNA and has G/C at the 5′ end of
the guide strand, A/U at the 5′ end of the passenger strand,
and more than 4 G/Cs within the seven-nucleotide region at the 5′
end of the guide strand. Class II siRNAs are those classified into
neither class I nor class III.In a distinct mode of action, siRNA suppresses mRNAs with only
partial sequence complementarity through a mechanism similar to that
of microRNA (miRNA)-mediated RNA silencing. This phenomenon causes
off-target effect by siRNAs. The off-target transcripts have complementary
sequences with the siRNA seed region (nucleotides 2–8) in their
3′ untranslated regions (UTRs).[21−28] In the human RISC, the backbone phosphates of the siRNA seed nucleotides
are ordered on a quasi-helical structure on the surface of the AGO
protein to serve as the entry or nucleation site for mRNA in the A-helix
form.[29,30] This seed-dependent off-target effect is
highly correlated with the thermodynamic stability in the duplex formed
between the siRNA seed region and its target mRNAs: the higher the
seed-target base-pairing stability, the higher the off-target effect.[31] Since the thermodynamic stability is nucleotide
sequence-dependent, it is necessary to select siRNA with a seed sequence
with lower thermodynamic stability to avoid off-target effects. However,
this process decreases the number of selectable siRNAs to 2.1% among
all of the possible 21 nucleotide sequences in humans.[32] It was demonstrated that a few types of modifications
in the seed region affect the seed-matched (SM) off-target effects:
2′-O-methyl (OMe) modification of the second
position of the siRNA guide strand has been reported to reduce off-target
effect without severely reducing RNAi activity and unlocked nucleic
acid modification of the seventh position also reduced SM off-target
effects.[33,34] Furthermore, we have revealed that the introduction
of 2′-OMe into nucleotides 2–8 in the siRNA guide strand
reduces off-target effects by inducing the steric hindrance of duplex
formation between the siRNA guide strand and mRNA on the AGO protein
without affecting RNAi activity.[35] As for
the non-seed region, 2′-OMe modifications at position 14 and
3′ termini were also shown to affect RNAi activities.[36,37]In this study, we performed the more detailed experiments
on the
position-dependent effect of 2′-OMe modification in the siRNA
seed region and found that the siRNA seed region is composed of two
functionally different domains in response to 2′-OMe modifications:
nucleotides 2–5 and 6–8. The 2′-OMe modifications
at positions 2–5 function to reduce off-target activity due
to steric hindrance without affecting completely matched (CM) on-target
RNAi activity, but those at positions 6–8 enhance both on-target
and most of the off-target activities.
Results
and Discussion
Effects of Sequential 2′-OMe
Modifications
in the Seed Region of the siRNA Guide Strand on RNAi and Off-Target
Activities
In our previous report, the introduction of 2′-OMe
into the siRNA seed region (nucleotides 2–8) reduced off-target
activity without affecting RNAi activity.[35] To investigate the position-dependent effects of 2′-OMe modifications
in the siRNA seed region in more detail, RNAi and seed-dependent off-target
activities of the sequential 2′-OMe modifications in the siRNA
seed region were investigated using luciferase reporter assays (Figure A). The class I siRNAs
against human vimentin (siVIM-270) and the clathrin heavy chain (siCLTC-2416)
were used for the reporter assays (Figure B,C).
Figure 2
Effects of 2′-OMe modifications
of the siRNA guide strand
on RNAi and off-target activities. (A) Schematic representation of
RNAi (left) and off-target (right) reporter assays. The psiCHECK-1
plasmids containing CM or three tandem repeats of SM sequences of
the siRNA guide strand in the 3′ UTR of the Renilla luciferase gene were used for RNAi and off-target
activity assays, respectively. The RNAi activities (left bar graphs)
and off-target activities (right bar graphs) of (B) siVIM-270 and
its modified siRNAs and (C) siCLTC-2416 and its modified siRNAs were
measured. Each upper sequence indicates the sequence of the passenger
strand from 5′ to 3′; the lower sequence indicates the
guide strand sequence from 3′ to 5′. Pink indicates
positions or nucleotides modified with 2′-OMe. siRNA against
green fluorescent protein (GFP) was used as the control siRNA (siCont).
Each reporter assay was performed at concentrations of 0.0005, 0.005,
0.05, 0.5, or 5 nM siRNA. The horizontal bars indicate the relative
luciferase activity (relative luc act). Results are presented as the
mean and standard deviation of three independent experiments.
Effects of 2′-OMe modifications
of the siRNA guide strand
on RNAi and off-target activities. (A) Schematic representation of
RNAi (left) and off-target (right) reporter assays. The psiCHECK-1
plasmids containing CM or three tandem repeats of SM sequences of
the siRNA guide strand in the 3′ UTR of the Renilla luciferase gene were used for RNAi and off-target
activity assays, respectively. The RNAi activities (left bar graphs)
and off-target activities (right bar graphs) of (B) siVIM-270 and
its modified siRNAs and (C) siCLTC-2416 and its modified siRNAs were
measured. Each upper sequence indicates the sequence of the passenger
strand from 5′ to 3′; the lower sequence indicates the
guide strand sequence from 3′ to 5′. Pink indicates
positions or nucleotides modified with 2′-OMe. siRNA against
green fluorescent protein (GFP) was used as the control siRNA (siCont).
Each reporter assay was performed at concentrations of 0.0005, 0.005,
0.05, 0.5, or 5 nM siRNA. The horizontal bars indicate the relative
luciferase activity (relative luc act). Results are presented as the
mean and standard deviation of three independent experiments.The 2′-OMe modifications were sequentially
introduced from
nucleotide 2–11 in siVIM-270 and to nucleotide 8 in siCLTC-2416.
The RNAi activities of both siVIM-270 and siCLTC-2416 were similar
and obviously high, even when 2′-OMe was introduced into any
position in their seed regions (IC50s were 11–46
and 4–18 pM, respectively) (Figure B,C and Supporting Information Table S1). However, the 2′-OMe modifications showed clear
effects on the off-target activities. The off-target activities of
unmodified siVIM-270 and siCLTC-2416 gradually decreased along with
the increase of 2′-OMe-modified nucleotides from position 2–5,
then reached a plateau, and the off-target activities increased gradually
after position 5 (Figure B,C and Supporting Information Table
S1).
Functionally Different Effects of the 2′-OMe
Modifications of Nucleotides 2–5 and 6–8 in the siRNA
Seed Region on RNAi and Off-Target Activities
To investigate
the functional differences of nucleotides 2–5 and 6–8,
the RNAi and off-target activities of siRNAs with 2′-OMe modifications
at either position were compared in detail. The RNAi activity of siVIM-270_2-5
showed no substantial loss compared to that of unmodified siVIM-270,
and siVIM-270_6-8/siVIM-270_7-8 showed levels of RNAi activities similar
to the unmodified siVIM-270. The off-target activity of siVIM-270_2-5
was almost completely eliminated, but those of both siVIM-270_6-8
and siVIM-270_7-8 were similar to that of unmodified siVIM-270. siVIM-270_2-8
exhibited intermediate RNAi and off-target activities (Figure B and Supporting Information Table S1). The RNAi activity of siCLTC-2416_2-5
was also only slightly reduced compared to that of unmodified siCLTC-2416,
but its off-target activity was greatly reduced (Figure C and Supporting Information Table S1). The off-target activity of siCLTC-2416_2-8
was intermediate between siCLTC-2416_2-5 and siCLTC-2416_7-8, although
very close to that of siCLTC-2416_7-8. We further investigated the
effects of 2′-OMe modifications at positions 2–5 and
6–8 using eight additional class I siRNAs: siCCNC-571, siHTT-5155,
siOCT-797, siPLS3-1310, siPLS3-1528, siVIM-733, siMC4R-490, and siOCT-670
(Supporting Information Table S2). The
2′-OMe modifications at positions 2–5 evidently reduced
off-target effects compared to their unmodified ones in most of all
siRNAs. These modifications showed almost no or slight effects on
the RNAi activities of siCCNC-571, siHTT-5155, siOCT-797, siPLS3-1310,
and siPLS3-1528 (Figure and Supporting Information Table S1).
However, the RNAi effects of siVIM-733, siMC4R-490, and siOCT-670
were severely reduced. Even in these cases, when the 2′-OMe
modifications were introduced at positions 2–4 or 3–5,
the RNAi activities of siMC4R-490 and siOCT-670 were drastically recovered.
The results of these 10 class I siRNAs revealed that the 2′-OMe
modifications at positions 2–5 (or 3 among 4 nucleotides at
positions 2–5) are sufficient to inhibit the off-target effect
without affecting the substantial RNAi activity.
Figure 3
Effects of 2′-OMe
modifications at positions 2–5,
6–8 (7–8), or both on RNAi and off-target activities.
RNAi (left bar graphs) and off-target activities (right bar graphs)
of (A) siCCNC-571, (B) siHTT-5155, (C) siOCT-797, (D) siPLS3-1310,
(E) siPLS3-1528, (F) siVIM-733, (G) siMC4R-490, and (H) siOCT-670
and their modified siRNAs. Each upper sequence indicates the sequence
of the passenger strand from 5′ to 3′; the lower sequence
indicates the guide strand sequence from 3′ to 5′. Pink
indicates the positions or nucleotides modified with 2′-OMe.
siRNA against GFP was used as control siRNA (siCont). Each reporter
assay was performed at the concentrations indicated. The horizontal
bars indicate relative luciferase activity (relative luc act). Results
are presented as the mean and standard deviation of three independent
experiments.
Effects of 2′-OMe
modifications at positions 2–5,
6–8 (7–8), or both on RNAi and off-target activities.
RNAi (left bar graphs) and off-target activities (right bar graphs)
of (A) siCCNC-571, (B) siHTT-5155, (C) siOCT-797, (D) siPLS3-1310,
(E) siPLS3-1528, (F) siVIM-733, (G) siMC4R-490, and (H) siOCT-670
and their modified siRNAs. Each upper sequence indicates the sequence
of the passenger strand from 5′ to 3′; the lower sequence
indicates the guide strand sequence from 3′ to 5′. Pink
indicates the positions or nucleotides modified with 2′-OMe.
siRNA against GFP was used as control siRNA (siCont). Each reporter
assay was performed at the concentrations indicated. The horizontal
bars indicate relative luciferase activity (relative luc act). Results
are presented as the mean and standard deviation of three independent
experiments.We also investigated the effects
of 2′-OMe modifications
in class II and III siRNAs. The siVIM-333, siGRK4-189, siVM-602, siFLT3-2493,
and siH3FA-73 are class II siRNAs, and the siVIM-491, siKRAS-25, siBRCA2-1104,
siGNAQ-616, and siTGFBR2-1648 are class III (Supporting Information Table S2). The 2′-OMe modifications at positions
2–5 in almost all of them reduced both RNAi and off-target
activities compared to those of unmodified siRNAs, but 2′-OMe
modifications at positions 6–8 enhanced both RNAi and off-target
activities (Supporting Information Figures
S1 and S2 and Table S3).These findings suggest that nucleotides
2–5 and 6–8
have different functions. The 2′-OMe modifications at positions
2–5 (or 3–5/2–4) function to reduce the off-target
activities without inducing considerable effects on the RNAi activities.
Such effects are clearly observed mainly in class I siRNAs probably
because the RNAi activities of class I siRNAs are intrinsically strong.
In class II and III siRNAs, the RNAi effects were explicitly reduced
by siRNAs with 2′-OMe modifications at positions 2–5.
However, the 2′-OMe modifications at positions 6–8 enhanced
both RNAi and off-target activities, and these effects are obviously
observed in class II and III siRNAs and ambiguous in class I siRNA
since the RNAi effects of class I siRNAs are originally strong. The
integrated results of each class of siRNA suggest that the 2′-OMe
modifications at positions 2–5 reduced the off-target effect
by steric hindrance, but the 2′-OMe modifications at positions
6–8 caused an opposite effect on those at positions 2–5.
Effects of 2′-OMe Modifications at
Positions 2–5 and 6–8 in the siRNA Seed Region on the
Expression of Endogenous Genes
To investigate genome-wide
off-target effects of siVIM-270 with 2′-OMe modifications at
positions 2–5 or 6–8, microarray analysis was performed.
Unmodified and modified siVIM-270s were transfected into HeLa cells,
separately, and total RNA was purified from the cells 1 day later
and subjected to microarray analyses. The MA plots (M = intensity
ratio, A = average intensity) of the microarray data indicated changes
in the expression levels of the transcripts, and the cumulative distribution
indicated the average fold changes of the transcripts with SM sequences
in their 3′ UTRs compared to those with non-SM transcripts
(Figure A–H).
The expression level of the completely-matched (CM) target gene, vimentin, was obviously downregulated by any siRNA at the
similar level, although siVIM-270_6-8 showed slightly stronger RNAi
activity compared to other siRNAs (Figure I). The difference in the mean log2 fold changes of SM or non-SM transcripts of the siVIM-270 guide
strand was calculated as an indicator of the degree of off-target
effects (Figure J).
The unmodified siVIM-270 and siVIM-270_6-8 showed significant off-target
effects, but siVIM-270_2-5 and siVIM-270_2-8 exhibited no or little
off-target effects. These results suggest that off-target effects
on the endogenous genes are clearly prevented by 2′-OMe modifications
at positions 2–5. In addition, it was noted that microarray
data are almost linear with those of the quantitative RT-PCR (qRT-PCR)
(Supporting Information Figure S3), indicating
that the results of microarray analysis and those of the qRT-PCR are
essentially identical to each other.
Figure 4
Microarray analysis for the expression
of the target vimentin gene and SM off-target genes
of siVIM-270. (A–D) MA plots
of the microarray date using the cells transfected with unmodified
siVIM-270, siVIM-270_2-5, siVIM-270_6-8, and siVIM-270_6-8. The vertical
bars indicate log2 fold changes of signal intensities in
each sample to those of mock transfection (M value),
and the horizontal bars indicate the averaged log10 signal
intensities of mock and each siRNA transfection (A value). The dark-blue dots indicate the transcripts with SM sequences,
and the light blue dots indicate the other transcripts. The pink arrowheads
indicate vimentin. (E–H) Cumulative distributions.
The horizontal bars indicate the M values of (A),
and the vertical bars indicate the cumulative fractions of transcripts.
The red lines indicate the cumulative curves of SM transcripts, and
the black lines indicate the cumulative curves of the other non-SM
transcripts. The downregulation of SM transcripts is shown by the
fold changes in the expression of SM transcripts compared to that
of the other non-SM transcripts. Each p-value was
determined by the Wilcoxon rank sum test. (I) Expression levels of
the target vimentin gene by the transfection of unmodified
siVIM-270 or 2′-OMe-modified siVIM-270s. The horizontal bar
indicates the signal intensity of the vimentin gene
relative to the mock sample. (J) Seed-dependent off-target effects
of unmodified siVIM-270 or 2′-OMe-modified siVIM-270s. The
horizontal bar indicates the mean log2 fold change of the
off-target transcripts in the cells transfected with unmodified siVIM-270
or 2′-OMe-modified siVIM-270s. Each p-value
was determined by the Wilcoxon rank sum test (*p <
0.01). n.s., not significant.
Microarray analysis for the expression
of the target vimentin gene and SM off-target genes
of siVIM-270. (A–D) MA plots
of the microarray date using the cells transfected with unmodified
siVIM-270, siVIM-270_2-5, siVIM-270_6-8, and siVIM-270_6-8. The vertical
bars indicate log2 fold changes of signal intensities in
each sample to those of mock transfection (M value),
and the horizontal bars indicate the averaged log10 signal
intensities of mock and each siRNA transfection (A value). The dark-blue dots indicate the transcripts with SM sequences,
and the light blue dots indicate the other transcripts. The pink arrowheads
indicate vimentin. (E–H) Cumulative distributions.
The horizontal bars indicate the M values of (A),
and the vertical bars indicate the cumulative fractions of transcripts.
The red lines indicate the cumulative curves of SM transcripts, and
the black lines indicate the cumulative curves of the other non-SM
transcripts. The downregulation of SM transcripts is shown by the
fold changes in the expression of SM transcripts compared to that
of the other non-SM transcripts. Each p-value was
determined by the Wilcoxon rank sum test. (I) Expression levels of
the target vimentin gene by the transfection of unmodified
siVIM-270 or 2′-OMe-modified siVIM-270s. The horizontal bar
indicates the signal intensity of the vimentin gene
relative to the mock sample. (J) Seed-dependent off-target effects
of unmodified siVIM-270 or 2′-OMe-modified siVIM-270s. The
horizontal bar indicates the mean log2 fold change of the
off-target transcripts in the cells transfected with unmodified siVIM-270
or 2′-OMe-modified siVIM-270s. Each p-value
was determined by the Wilcoxon rank sum test (*p <
0.01). n.s., not significant.
Computational Simulation of the Mechanism
for Enhancing RNAi/Off-Target Activities by 2′-OMe Modifications
at Positions 6–8
To reveal the mechanism by which
2′-OMe modifications at positions 6–8 enhance RNAi and
off-target activities, we computationally simulated 2′-OMe-modified
RNA structures on the AGO protein using density functional theory
(DFT) at the ωB97X-D/6-31G(d) level. The unmodified 5′-AUU-3′
RNA structure {nucleotides 6–8 [A(6), U(7), and U(8)] of the
guide RNA} on the human AGO protein reported by Schirle et al.[38] was used, with side chains of His (H753), Lys
(K709), Met (M364), and Ile (I365) residues (PDB: 4W5O). The AGO protein
organizes the seed region by forming hydrogen bonds with the phosphate
backbone at positions 3–6 of the guide RNA.[30,38] The residues which form hydrogen bonds with the phosphate at position
6 are H753 and K709. Therefore, in the current computational system,
these two residues, H753 and K709, were included with their Cα
atoms being fixed such that the organization scheme at positions 3–6
of the guide RNA by the AGO protein is reflected in the current calculations.
Furthermore, in the current system, the residues M364 and I365 were
included to take account of the influence of helix-7. Full geometry
optimization was performed with only the Cα atoms of H753 and
K709 being fixed (Figure A). The same procedure was applied to single-stranded RNA
structures in which the sugars of A(6), U(7), U(8), A(6)U(7), A(6)U(8),
U(7)U(8), or A(6)U(7)U(8) were modified with 2′-OMe (Figure B–H).
Figure 5
Computational
simulation of RNA structures with 2′-OMe modifications
at nucleotides 6–8. (A–H) 5′-AUU-3′ RNA
structures of (A) unmodified siRNA and siRNAs with 2′-OMe modification
at the (B) A(6), (C) U(8), (D) A(6)U(8), (E) U(7), (F) A(6)U(7), (G)
U(7)U(8), or (H) A(6)U(7)U(8) nucleotides of the guide RNA with His
(H753), Lys (K709), Met (M364), and Ile (I365) residues. The structures
in the figures (A–H) are aligned to superimpose C5′,
C4′, C3′, and O3 atoms of U(7) such that the differences
in the conformations in (A–H) can be seen adequately. Geometry
optimization was done with only the Cα atoms of H753 and K709
fixed. The base parts of U(7) and U(8) are indicated in pink and yellow,
respectively. In (B–D), U(8) is orthogonal to U(7). In (E–H),
U(8) is aligned such that the hydrogen-bonding interaction may be
formed with target/off-target mRNA. (I) Sequence of siVIM-491 and
its modified siRNAs. Each upper sequence indicates the sequence of
the passenger strand from 5′ to 3′; the lower sequence
indicates the guide strand sequence from 3′ to 5′. Pink
indicates positions or nucleotides modified with 2′-OMe. siRNA
against GFP was used as control siRNA (siCont). The results of reporter
assays are separately shown for each siRNA concentration: (J) 0.05,
(K) 0.5, or (L) 5 nM siRNA for RNAi activities and (M) 0.5, (N) 5,
or (O) 50 nM siRNA for off-target activities. The horizontal bars
indicate relative luciferase activity (relative luc act). Results
are presented as the mean and standard deviation of three independent
experiments. Each p-value was determined by Student’s t-test (*p < 0.05). n.s., not significant.
Computational
simulation of RNA structures with 2′-OMe modifications
at nucleotides 6–8. (A–H) 5′-AUU-3′ RNA
structures of (A) unmodified siRNA and siRNAs with 2′-OMe modification
at the (B) A(6), (C) U(8), (D) A(6)U(8), (E) U(7), (F) A(6)U(7), (G)
U(7)U(8), or (H) A(6)U(7)U(8) nucleotides of the guide RNA with His
(H753), Lys (K709), Met (M364), and Ile (I365) residues. The structures
in the figures (A–H) are aligned to superimpose C5′,
C4′, C3′, and O3 atoms of U(7) such that the differences
in the conformations in (A–H) can be seen adequately. Geometry
optimization was done with only the Cα atoms of H753 and K709
fixed. The base parts of U(7) and U(8) are indicated in pink and yellow,
respectively. In (B–D), U(8) is orthogonal to U(7). In (E–H),
U(8) is aligned such that the hydrogen-bonding interaction may be
formed with target/off-target mRNA. (I) Sequence of siVIM-491 and
its modified siRNAs. Each upper sequence indicates the sequence of
the passenger strand from 5′ to 3′; the lower sequence
indicates the guide strand sequence from 3′ to 5′. Pink
indicates positions or nucleotides modified with 2′-OMe. siRNA
against GFP was used as control siRNA (siCont). The results of reporter
assays are separately shown for each siRNA concentration: (J) 0.05,
(K) 0.5, or (L) 5 nM siRNA for RNAi activities and (M) 0.5, (N) 5,
or (O) 50 nM siRNA for off-target activities. The horizontal bars
indicate relative luciferase activity (relative luc act). Results
are presented as the mean and standard deviation of three independent
experiments. Each p-value was determined by Student’s t-test (*p < 0.05). n.s., not significant.After the geometry optimization, van der Waals
interactions with
the hydrophobic side chains of M364 and I365 appeared to impact the
directions of A(6) and U(7) bases such that the formation of base
pairs may be possible between the guide RNA and target/off-target
mRNAs. This comes out in the glycosyl angles (χ dihedral angles)
of the RNAs, which are summarized in Supporting Information Table S4. As shown in Table S4, the χ dihedral angles of A(6), U(7), and U(8) of
unmodified RNA (Figure A) are 209.8, 223.7, and 272.0°, respectively. The χ dihedral
angles of A(6) and U(7) of unmodified RNA are close to, but that of
U(8) is rather larger than the average χ value of double-helical
A-RNA (198.2°).[39] In the 2′-OMe
modified RNA structures (Figure –H and Supporting Information Table S4), these χ dihedral angles of A(6) and U(7) tend to
decrease, being closer to the average χ value of double-helical
A-RNA (198.2°).[39] It is noteworthy
that in RNA structures with the 2′-OMe modification in U(7),
including U(7) (Figure E), A(6)U(7) (Figure F), U(7)U(8) (Figure G), and A(6)U(7)U(8) (Figure H), the methyl group of the 2′-OMe of U(7) creates
van der Waals interaction with the U(8) base in addition to that by
M364, which results in the χ dihedral angle of U(8) being 202°–207°
(Supporting Information Table S4) which
is suitable for base-pairing with target/off-target mRNAs. However,
in the RNA structures with 2′-OMe modification at positions
other than A(7), such as A(6) (Figure B), U(8) (Figure C), or A(6)U(8) (Figure D), U(8) was positioned orthogonal to U(7), with χ
of U(8) being larger than ∼230°. In these cases, base
pairings between U(7)/U(8) nucleotides in the guide RNA and target/off-target
mRNAs are considered to be difficult. Thus, 2′-OMe modification
at U(7) may support the U(8) direction easy to base-pair the target
and off-target mRNAs.Here, in the current calculations, DFT
at the ωB97X-D/6-31G(d)
level of theory was employed to reveal the impact of 2′-OMe
modifications at positions 6–8. Large-scale molecular dynamics
(MD) simulations using molecular mechanical (MM) force field have
recently been applied to RNA dynamics[40] including a system of chemically modified siRNA and AGO protein.[41] MD simulations with the MM force field are useful
to describe dynamical features of biological systems. In the current
calculations, we reveal the impact of 2′-OMe modifications
at positions 6–8 in the seed region with the AGO protein by
means of geometry optimization using DFT at the ωB97X-D/6-31G(d)
level, which is known as appropriate to assess van der Waals interactions
within large systems.[42]The structural
analyses revealed that part of the seed region of
the single-stranded guide RNA on the human AGO protein is organized
in a helical conformation, and its base stacking is interrupted by
a kink between nucleotides 6 and 7.[30,43−46] This kink is promoted by the helix-7 domain, including M364 and
I365 residues of human AGO2, by inserting helix-7 between nucleotides
6 and 7. Thus, helix-7 creates a steric barrier to base pairing beyond
nucleotide 5, namely, positions 6–8. However, the crystal structures
of the guide–target duplex on the AGO protein show that helix-7
shifts to dock into the minor groove of the guide–target duplex
in stable pairing. It is suggested that helix-7 may position the 3′
end of the guide strand for pairing to incoming RNAs. Thus, nucleotides
2–5 remain stable and immobile on the surface of the AGO protein
in both single-stranded and double-stranded forms. Furthermore, the
single-molecule analyses for base pairing between guide RNA and seed-paired
target RNA on the mammalian AGO protein revealed that mismatches in
nucleotides 2–5 of guide RNA are far more sensitive than those
in nucleotides 6–8.[47,48] These prior studies
suggest that base pairing on AGO shows higher sensitivity to conformation
changes in nucleotides 2–5 than to those in nucleotides 6–8.
Thus, the 2′-OMe modifications at positions 2–5 disturb
the steady loading onto the AGO protein via steric hindrance, resulting
in the inhibition of base pairing with target/off-target mRNAs. By
contrast, the conformation of nucleotides 6–8 is flexible and
easy to be changed by the interaction with helix-7; thus, 2′-OMe
modifications at positions 6–8 have little or no effect on
base pairing and may dynamically interact with target/off-target mRNAs
to enhance the base-pairing stability.
Experimental
Validation for the Enhancement
of RNAi/Off-Target Activities by the 2′-OMe Modification of
Nucleotide 7
Computational validation suggested that the
2′-OMe modification of the nucleotide 7 produces the largest
effect in terms of base pairing with target/off-target mRNAs. We then
validated the result experimentally using siVIM-491 (Figure I). The effects of 2′-OMe
modifications at positions 6–8 on RNAi/off-target activities
were clearly observed by siVIM-491 because its activities were intrinsically
weak (Supporting Information Figure S2A).
The results of the RNAi/off-target activities were compared at each
concentration of siRNA. When the siRNA concentrations were at 0.05
(Figure J) and 0.5
nM (Figure K), siVIM-491_6
and siVIM-491_7 significantly increased RNAi activities compared to
unmodified siVIM-491, but siVIM-491_8 did not. When two or three 2′-OMe
modifications were simultaneously introduced into siRNAs (siVIM-491_6-7,
siVIM-491_7-8, siVIM-491_6+8, and siVIM-491_6-8), RNAi activities
were also significantly enhanced. However, when the siRNA concentration
was increased to 5 nM (Figure L), clear differences in RNAi activities in siVIM-491_6, siVIM-491_7,
and siVIM-491_8 were not observed, and siVIM-491_6-7, siVIM-491_7-8,
and siVIM-491_6-8 exhibited significant RNAi activities. As for the
off-target activity, siRNAs containing 2′-OMes at least at
position 7 (siVIM-491_6-7, siVIM-491_7-8, or siVIM-491_6-8) significantly
increased the off-target activities at 0.5 nM siRNA (Figure M), and siVIM-491_7 also additively
increased the off-target activity at 5 nM siRNA (Figure N). When siRNA concentration
was 50 nM, siVIM-491_6 also increased the off-target activity (Figure O). Thus, these results
clearly suggest that 2′-OMe modification at position 7 is the
most effective modification for RNAi/off-target activities, and 2′-OMe
modification at position 6 contributed to the secondary highest effect,
but 2′-OMe modification at position 8 exhibited almost no effect.We also validated the effects of 2′-OMe modification at
position 7 in addition to positions 2–5 (siCLTC-2416_2-5) because
the functions of the nucleotides at positions 2–5 and 6–8
appear to differ. Although unmodified siCLTC-2416 exhibited strong
RNAi and off-target activities, the RNAi and off-target activities
of siCLTC-2416_2-5 were reduced (Supporting Information Figure S4 and Table S1). The off-target activities of siCLTC-2416_2-6
and siCLTC-2416_2-5+7 were stronger than that of siCLTC-2416_2-5+8.
Furthermore, the off-target activities of siCLTC-2416_2-7 and siCLTC-2416_2-5+7-8
were stronger than that of siCLTC-2416_2-5+6+8. The off-target activity
of siCLTC-2416_2-8 was similar to those of siCLTC-2416_2-7 and siCLTC-2416_2-5+7-8.
However, the RNAi activities of these 2′-OMe-modified siRNAs
were similar to that of siCLTC-2416_2-5, except for siCLTC-2416_2-5+8.
Thus, these results suggest that the 2′-OMe modification at
position 7, in addition to positions 2–5, is the most effective
modification for influencing RNAi/off-target activities, similar to
the results using siVIM-491 without 2′-OMe modifications at
positions 2–5 (Figure I–O). However, 2′-OMe modification at position
6 produced an effect similar to that at position 7 in the case of
siCLTC-2416. A possible explanation is that the functions of nucleotides
6 and 7 may slightly differ according to the siRNA sequence. As for
other chemical modifications, it was reported that altritol nucleic
acids and 2′-fluorinated Northern-methanocarbacyclic (2′-F-NMC)
modifications at position 7 are also best accommodated and tolerated
with the highest performance for the reduction of target gene expression.[49,50]
Effects of 2′-OMe Modifications on
the AGO Loading Levels of siRNA Guide Strands
All classes
of siRNAs with 2′-OMe modifications at positions 2–5
showed strongly reduced off-target activities. By contrast, the same
siRNAs with 2′-OMe modifications at positions 6–8 exhibited
enhanced off-target activities (Figures and 4, Supporting Information Figures S1 and S2). Thus,
it was possible to assume that the amount of AGO-loaded guide strands
with 2′-OMe modifications at positions 2–5 was lower
compared to that with 2′-OMe modifications at positions 6–8.
To investigate the effect of 2′-OMe modifications on AGO loading
levels, we performed RNA and protein immunoprecipitation experiments
using the anti-AGO2 antibody and quantified the amount of guide strands
in the immunoprecipitates in the cells transfected with each siRNA
(Figure A). The AGO2
protein and trinucleotide repeat containing 6A (TNRC6A) proteins,
which interact with AGO (Figure A),[51−53] were detected in the immunoprecipitates, indicating
that the immunoprecipitation was successfully performed (Figure B). The Renilla luciferase protein was clearly observed in
the lysate of cells transfected with control siRNA (siCont), siVIM-270_2-5,
and siVIM-270_2-8, but luciferase levels were reduced by the transfection
of unmodified siVIM-270 and siVIM-270_6-8 (Figure C), consistent with the results of the reporter
assay (Figure B).
Furthermore, the qRT-PCR using stem-loop PCR primers specific for
the siVIM-270 guide strand was performed (Figure D). The amount of guide strands in the immunoprecipitate
was almost similar regardless of 2′-OMe modifications (Figure E). These results
are consistent with our previous result of structural simulation[35] that the 2′-OMe-modifications in the
siRNA seed region did not affect the interaction with the AGO protein.
Figure 6
Effects
of the 2′-OMe modifications of the siRNA guide strand
on AGO2 loading of the guide strand. (A) Schematic presentation of
RNA and protein immunoprecipitation experiments. After immunoprecipitation,
the AGO2 loading levels of the guide strand were quantified. (B) Western
blot of input samples (lanes 1–5), immunoprecipitates with
IgG (IgG-IP; lanes 6, 8, 10, 12, and 14), and immunoprecipitates with
the anti-AGO2 antibody (AGO2-IP; lanes 7, 9, 11, 13, and 15). Unmodified
siVIM-270 or modified siRNAs with 2′-OMe modification at positions
2–5, 6–8, or 2–8 were transfected into HeLa cells
with a psiCHECK-VIM270-SM reporter construct and immunoprecipitated
with the anti-AGO2 antibody or anti-mouse IgG antibody as a negative
control. Endogenous TNRC6A, AGO2, and α-tubulin were detected
with specific antibodies, respectively. (C) Western blot of Renilla luciferase in the input samples (lanes 1–5).
α-Tubulin was detected as a control. (D) Schematic representation
of stem-loop RT-PCR specific for the siVIM-270 guide strand. Black
indicates the sequences of the siVIM-270 guide strand. Red and orange
indicate the sequences of stem-loop reverse-transcription primers
specific for the siVIM-270 guide strand. Blue indicates cDNA sequences
generated by reverse transcription. Green indicates the sequences
of forward PCR primers specific for the siVIM-270 guide strand. Orange
indicates the sequences of reverse primers. Light blue indicates the
orientations of extension using forward primers. (E) Results of quantification
of the siVIM-270 guide strand in each fraction. The copy numbers were
calculated via an absolute quantification method using standard curves
of each synthesized siRNA and normalized to the copy numbers of the
guide strand in each input fraction. siRNA against GFP was used as
control siRNA (siCont). Results are presented as the mean and standard
deviation of three independent experiments. Each p-value was determined by Student’s t-test.
n.s., not significant.
Effects
of the 2′-OMe modifications of the siRNA guide strand
on AGO2 loading of the guide strand. (A) Schematic presentation of
RNA and protein immunoprecipitation experiments. After immunoprecipitation,
the AGO2 loading levels of the guide strand were quantified. (B) Western
blot of input samples (lanes 1–5), immunoprecipitates with
IgG (IgG-IP; lanes 6, 8, 10, 12, and 14), and immunoprecipitates with
the anti-AGO2 antibody (AGO2-IP; lanes 7, 9, 11, 13, and 15). Unmodified
siVIM-270 or modified siRNAs with 2′-OMe modification at positions
2–5, 6–8, or 2–8 were transfected into HeLa cells
with a psiCHECK-VIM270-SM reporter construct and immunoprecipitated
with the anti-AGO2 antibody or anti-mouse IgG antibody as a negative
control. Endogenous TNRC6A, AGO2, and α-tubulin were detected
with specific antibodies, respectively. (C) Western blot of Renilla luciferase in the input samples (lanes 1–5).
α-Tubulin was detected as a control. (D) Schematic representation
of stem-loop RT-PCR specific for the siVIM-270 guide strand. Black
indicates the sequences of the siVIM-270 guide strand. Red and orange
indicate the sequences of stem-loop reverse-transcription primers
specific for the siVIM-270 guide strand. Blue indicates cDNA sequences
generated by reverse transcription. Green indicates the sequences
of forward PCR primers specific for the siVIM-270 guide strand. Orange
indicates the sequences of reverse primers. Light blue indicates the
orientations of extension using forward primers. (E) Results of quantification
of the siVIM-270 guide strand in each fraction. The copy numbers were
calculated via an absolute quantification method using standard curves
of each synthesized siRNA and normalized to the copy numbers of the
guide strand in each input fraction. siRNA against GFP was used as
control siRNA (siCont). Results are presented as the mean and standard
deviation of three independent experiments. Each p-value was determined by Student’s t-test.
n.s., not significant.Furthermore, in order
to exclude the possibility of non-specific
binding of siRNA with AGO2, the same binding assay was performed using
AGO2-Y529E protein. AGO2-Y529E is impaired in siRNA binding by the
substitution of tyrosine to glutamic acid at amino acid 529, which
is located in the binding pocket of AGO2 with the 5′-end of
the siRNA guide strand.[54] The pFLAG/HA-empty,
pFLAG/HA-AGO2, or pFLAG/HA-AGO2-Y529E expression construct was transfected
into HeLa cells with siVIM-270 or siVIM-270_2-5, and immunoprecipitation
was performed with the anti-FLAG antibody. The FLAG-AGO2 proteins
were clearly detected in the immunoprecipitates, indicating that the
immunoprecipitations were successfully performed (Supporting Information Figure S5A). The results of the qRT-PCR
indicated that the amounts of guide strands in the immunoprecipitates
were almost similar regardless of 2′-OMe modifications but
were significantly reduced by AGO2-Y529E compared to AGO2-WT (Supporting Information Figure S5B). Therefore,
it is considered that this binding assay certainly detects siRNAs
whose 5′-ends were stably located in the binding pockets of
AGO2 proteins without detecting nonspecific loading on the AGO protein.
Thus, these results suggest that 2′-OMe modification had almost
no effect on AGO loading.
Conclusions
We revealed that the siRNA seed region is composed of two differentially
responsive domains to 2′-OMe modifications: nucleotides 2–5
and 6–8. This is the first report to show the differences of
the functional machinery of these two domains; the 2′-OMe modifications
at nucleotides 2–5 function to reduce the off-target activity
due to steric hindrance without affecting on-target RNAi activity
mainly in class I siRNA, but those at nucleotides 6–8 enhance
both on-target and most of the off-target activities, especially in
class III siRNA (Figure ). Our computational simulation of 2′-OMe modification in
each of the nucleotides 6–8 proposed the possibility that the
nucleotide at position 7 exerts the strongest impact on base pairing
with target/off-target mRNA. Then, we demonstrated that 2′-OMe
modifications at positions 7 enhance RNAi/off-target activities. Furthermore,
our immunoprecipitation experiment clearly revealed that none of the
2′-OMe modifications affected the AGO loading efficiencies
of these 2′-OMe-modified siRNAs. Taken together, our studies
could provide expanded knowledge for the therapeutic application of
siRNA.
Figure 7
Model of the functional mechanism of each siRNA. In the case of
unmodified siRNA, the siRNA guide strand is stably loaded onto the
AGO protein, and it induces an off-target effect for off-target mRNAs
with seed complementarities and an RNAi effect for a target mRNA with
perfect sequence complementarity. The siRNA guide strand with 2′-OMe
of nucleotides 2–5 is also successfully loaded on AGO. However,
the base pairing at positions 2–5 between guide RNA and off-target
mRNAs causes steric hindrance, resulting in the inhibition of the
off-target effect. As for RNAi, it is considered that base-pairing
between nucleotides 6–21 and target mRNA is sufficient to induce
RNAi. Even though 2′-OMes are introduced into nucleotides 6–8,
these modifications do not induce steric hindrance on the AGO protein.
Therefore, RNAi and off-target effects are induced by an almost similar
manner as the unmodified siRNA. Furthermore, 2′-OMe modifications
of nucleotides 6–8, especially nucleotide 7, enhance both RNAi
and off-target effects.
Model of the functional mechanism of each siRNA. In the case of
unmodified siRNA, the siRNA guide strand is stably loaded onto the
AGO protein, and it induces an off-target effect for off-target mRNAs
with seed complementarities and an RNAi effect for a target mRNA with
perfect sequence complementarity. The siRNA guide strand with 2′-OMe
of nucleotides 2–5 is also successfully loaded on AGO. However,
the base pairing at positions 2–5 between guide RNA and off-target
mRNAs causes steric hindrance, resulting in the inhibition of the
off-target effect. As for RNAi, it is considered that base-pairing
between nucleotides 6–21 and target mRNA is sufficient to induce
RNAi. Even though 2′-OMes are introduced into nucleotides 6–8,
these modifications do not induce steric hindrance on the AGO protein.
Therefore, RNAi and off-target effects are induced by an almost similar
manner as the unmodified siRNA. Furthermore, 2′-OMe modifications
of nucleotides 6–8, especially nucleotide 7, enhance both RNAi
and off-target effects.
Experimental
Section
Cell Culture
Human HeLa cells were
cultured in Dulbecco’s modified Eagle’s medium (FUJIFILM
Wako, Osaka, Japan) containing 10% fetal bovine serum (BioWest, Nuaille,
France) and a 1% penicillin–streptomycin solution (FUJIFILM
Wako) at 37 °C with 5% CO2.
Chemical
Synthesis of siRNA Duplexes
RNA oligonucleotides corresponding
to the guide and passenger strands
of each siRNA were chemically synthesized (Gene Design, Osaka, Japan;
Shanghai Gene Pharma, Shanghai, China) and subsequently annealed to
form endogenous siRNA duplexes. All siRNA sequences used in this study
are summarized in Supporting Information Table S2.
Construction of CM and
SM Luciferase Reporters
All of the reporter plasmids used
in this study were constructed
according to the procedures shown in our previous report[35] and are listed in Supporting Information Tables S5 and S6. psiCHECK-CM and psiCHECK-SM reporter
constructs were, respectively, used to test the RNAi and off-target
effects of the corresponding siRNAs.
RNA Silencing
Activity Assay for the Renilla Luciferase
Gene
RNAi and off-target
activities were measured using the dual-luciferase reporter assay
system (Promega, Madison, WI, USA), as shown in our previous report,[35] except for using 0.01 μg of each psiCHECK
construct. An siRNA called siGY441, which did not target any CM- and
SM-reporter constructs, was used as an internal control.The
half-maximal inhibitory concentrations (IC50s) of the siRNAs
were estimated using the following linear model.A: concentration
when the
inhibitory efficiency is lower than 50%, B: concentration
when the inhibitory efficiency is higher than 50%, C: inhibitory efficiency in B,D:
inhibitory efficiency in A.The IC50s are listed in Supporting Information Tables S1 and S3.
Microarray
Analysis
A HeLa cell suspension
(0.5 × 105 cells/mL) was inoculated into a well of
a 24-well culture plate 1 day before transfection. The cells were
transfected with 100 nM of each siRNA using Lipofectamine 2000. At
24 h post-transfection, the cells were harvested from three wells
per sample. The total RNA was purified using FastGene RNA Premium
Kit (NIPPON Genetics, Tokyo, Japan). Quality check of the total RNA
and preparation of the microarray sample were performed as described
in our previous report.[35] RNA from mock-transfected
cells treated with the transfection reagent in the absence of siRNA
was used as a control, and the distributions of the signal intensities
of the transcripts were normalized across all samples by quantile
normalization.[55] The results are shown
in MA plots and cumulative accumulations.
Quantitative
RT-PCR
Total RNAs applied
for microarray analysis were used for qRT-PCR. RNA from mock-transfected
cells treated with the transfection reagent in the absence of siRNA
was used as a control. An aliquot of total RNA (1 μg) was reverse-transcribed
using High-Capacity cDNA Reverse Transcription Kits (Applied Biosystems,
Foster City, CA, USA). The mixture of synthesized cDNA, gene-specific
primer sets, and KAPA SYBR Fast qPCR Kit (NIPPON Genetics) was subjected
to the PCR. The levels of PCR products were monitored with a StepOnePlus
Real-Time PCR system (Applied Biosystems) and analyzed by the ΔΔCt method. The expression level of each sample was first
normalized to the amount of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and then to the mock-transfection control. The used primer
sets are listed in Supporting Information Table S7.
Computational Prediction
of the Structure
of Modified RNA
The Cartesian coordinates of the crystal
structure (PDB ID: 4W5O) were used as the initial geometry for 5′-AUU-3′ RNAs
in positions 6–8 from the 5′ end of the guide RNA loaded
on the AGO protein. Met364, Ile365, Lys709, and His753 of the AGO
protein were taken into account in the calculations, in which the
main chains of these amino acid residues were replaced by methyl groups
at the atoms bonded to Cα, and the terminal phosphates of 5′-AUU-3′
were capped with methyl groups (Supporting Information Figure S6). For modified 5′-AUU-3′ RNA, we introduced
2′-OMe modifications of all combinations at positions 6–8.
Full geometry optimization with the Cα atoms of Lys709 and His753
being fixed was performed at the theoretical level of ωB97X-D/6-31G(d).
All the calculations were done in the gas phase since we focused on
the local interactions between the side chains of several residues
of the AGO protein and the nucleotides 6–8 of the guide RNA
in the current system. The χ dihedral angles of the RNAs are
summarized in Supporting Information Table
S4. The energies are listed in Supporting Information Table S8 together with all Cartesian coordinates.
Immunoprecipitation by the Anti-AGO2 Antibody
A HeLa
cell suspension was plated into a 9 cm dish (1.0 ×
106 cells/dish) 1 day before transfection. The cells were
simultaneously transfected with 20 nM of each siRNA and 1 μg
of psiCHECK-SM reporter construct using Lipofectamine 2000. The cells
were harvested from four dishes per one sample, washed with PBS, and
lysed in cold lysis buffer (20 mM Tris-HCl [pH 7.5], 4 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 140 mM NaCl, 1 mM Na3VO4, 10 mM NaF, 0.5% NP-40, complete protease inhibitor, and
0.03 units RNase inhibitor) 24 h following transfection. For immunoprecipitation,
50 μL of Dynabeads Protein G (Thermo Fisher Scientific) was
conjugated with 2.5 μL of the mouse anti-AGO2 antibody (1.0
mg/mL, FUJIFILM Wako) or 6.25 μL of mouse IgG (0.4 mg/mL, Santa
Cruz Biotechnology, Dallas, TX, USA) as a negative control by rotation
at 4 °C for overnight. The cell lysates were then added to antibody-bound
Dynabeads Protein G and rotated at 4 °C for 2 h. The beads were
washed three times with the wash buffer (lysis buffer containing 300
mM NaCl) and twice with the lysis buffer. To elute the bound proteins
with RNA, 100 μL of the 2 × SDS-PAGE sample buffer (4%
(wt/vol) SDS, 0.1 M Tris-HCl (pH 6.8), 12% (vol/vol) β-mercaptoethanol,
20% (wt/vol) glycerol, and 0.01% (wt/vol) bromophenol blue) was added,
and the beads were heated at 70 °C for 10 min. The Dynabeads
were removed by using DynaMag (Thermo Fisher Scientific). Half of
the eluted supernatant was subjected to western blotting, and the
remaining was subjected to RNA extraction.To investigate the
nonspecific binding of siRNA on AGO2 protein, the cells were simultaneously
transfected with 5 μg of pFLAG/HA-empty, pFLAG/HA-Ago2-WT, or
pFLAG/HA-Ago2-Y529E constructed in our previous study[56] and 20 nM of each siRNA using Lipofectamine 2000. 1 day
after transfection, the cell lysates were prepared as shown above
and incubated with 50 μl of Dynabeads Protein G conjugated with
2.5 μL of the mouse anti-FLAG antibody (1.0 mg/mL, Merck, Darmstadt,
Germany) by constant rotation at 4 °C for 2 h. Then, the following
wash and elution steps were performed in the same manner as shown
above.
Western Blot
The eluate of the immunoprecipitate
was separated by SDS-PAGE and transferred to an Immobilon-P PVDF membrane
(Merck Millipore, Burlington, MA, USA) using the Mini Trans-Blot Cell
(Bio-Rad, Hercules, CA, USA). The membranes were blocked for 1 h at
room temperature in TBST (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, and
0.1% Tween) supplemented with 5% Difco skimmed milk (FUJIFILM Wako).
Blocked membranes were incubated with each of the primary antibodies
at 4 °C overnight in TBST +5% skimmed milk or the Can Get Signal
immunoreaction enhancer solution (TOYOBO, Osaka, Japan). Then, the
membranes were washed three times for 10 min at room temperature with
TBST and then incubated for 1 h at room temperature with the secondary
antibodies. The primary and secondary antibodies are shown in Supporting Information Table S9. After being
washed three times for 10 min in TBST at room temperature, the membrane
was incubated with the ECL Prime Western Blotting Detection Reagent
(GE Healthcare), and signals were detected by FUSION (VILBER, Collégien,
France).
Quantification of siRNAs Loaded onto AGO2
ISOGEN (Nippon Gene, Tokyo, Japan) was added to the eluate of the
immunoprecipitation by the anti-AGO2 antibody or mouse IgG. It was
also added to 10% of the cell lysates as input samples. RNA extraction
was performed according to the manufacturer’s protocol. An
aliquot of RNA (80 ng) was reverse-transcribed using the stem-loop
primer specific for each strand of siRNA with High-Capacity cDNA Reverse
Transcription Kits. A mixture of the synthesized cDNA, siRNA-specific
forward primer, and loop-specific reverse primer was subjected to
PCR amplification using the KAPA SYBR Fast qPCR Kit. The levels of
PCR products were monitored using the StepOnePlus Real-Time PCR System,
and the copy numbers of each sample were calculated using the absolute
quantification method. To prepare the standard curve for each sample,
each synthesized siRNA (0.00005–5 ng) was similarly reverse-transcribed.
Each copy number from the immunoprecipitate was normalized to that
in the input fraction. The primer sets are listed in Supporting Information Table S7.
Authors: Jesper B Bramsen; Malgorzata M Pakula; Thomas B Hansen; Claus Bus; Niels Langkjær; Dalibor Odadzic; Romualdas Smicius; Suzy L Wengel; Jyoti Chattopadhyaya; Joachim W Engels; Piet Herdewijn; Jesper Wengel; Jørgen Kjems Journal: Nucleic Acids Res Date: 2010-05-07 Impact factor: 16.971